About Sunil Sharma
Form D filings for Stingray Therapeutics from 2020 to 2024 list Sunil Sharma as executive officer and director.
Sunil Sharma first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Sunil Sharma in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sunil Sharma works with at each company, as listed on that company's latest Form D.
Stingray Therapeutics, Inc. · Form D, May 14, 2024
JN
Jonathan Northrup
Chief Executive Officer and director
UB
Uma Bhatt
Executive officer and director